María Luisa Gutiérrez García

Author

Hospital Universitario Fundación Alcorcón ORCID

Also Known As

M Garcia, M Gutierrez, M Gutiérrez, M L Gutiérrez, M L Gutiérrez Garcia, M O Mendez Garcia, M. Garcia, M. Gutierrez, M. L. GUTIÉRREZ, M. L. Gutierrez

109

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Alcorcón Hospital Universitario 12 De Octubre Hospital Universitario de La Princesa Hospital Universitario Ramón y Cajal Hospital Universitario La Paz

About

María Luisa Gutiérrez García is an author at Hospital Universitario Fundación Alcorcón specializing in hepatology, medicine, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	860
2	Epidemiology	2	2	104
3	Health Sciences	1	1	730
4	Public Health	1	1	71
5	Diabetes	1	1	730

María Luisa Gutiérrez García

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade, Gastroenterology Metabolic SyndromeDiabetes ManagementHepatologyViral HepatitisLiver Physiology	2005	730
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study María Luisa Manzano, Rosa M. Morillas, Montserrat Garcı́a-Retortillo, PLoS ONE	2017	94
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis Sonia Alonso López, María Luisa Manzano, Francisco Gea, Hepatology	2020	93
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis Conrado Fernández‐Rodríguez, Julián Romero, Timothy J. Petros, Liver International	2004	83
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma Mar Riveiro‐Barciela, David Tabernero, José Luís Calleja, Digestive Diseases and Sciences HepatologySpanish CohortViral HepatitisMedicinePage-b Score	2017	71
The contribution of telemedicine to hepatitis C elimination in a correctional facility G Jiménez Galán, C Alía, Milagros Vegue González, Revista Española de Enfermedades Digestivas	2019	39
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid E. Ricart Gómez, Luisa García Buey, Esther Molina, Alimentary Pharmacology & Therapeutics	2020	39
Factors Influencing the Rate of Fibrosis Progression in Chronic Hepatitis C Conrado Fernández‐Rodríguez, María Luisa Gutiérrez García, Pilar López Serrano, Digestive Diseases and Sciences EpidemiologyHepatologyHepatitis CViral HepatitisLiver Physiology	2004	33
Labour productivity losses caused by premature death associated with hepatitis C in Spain Juan Oliva, Luz María Peña-Longobardo, Sonia Alonso Sáenz De Oger, European Journal of Gastroenterology & Hepatology	2015	25
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure Georg Semmler, Sonia Alonso López, Mònica Pons, Journal of Hepatology	2024	24

Page 1